Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 29, 2018 - Issue 1
Submit an article Journal homepage
407
Views
1
CrossRef citations to date
0
Altmetric
Other Disease

Atopic dermatitis 2017: where we were 10–15 years ago in psoriasis

Daniel J. NoLoma Linda University, School of Medicine, Loma Linda, CA, USA; View further author information
,
Mina AminUniversity of California, Riverside School of Medicine, Riverside, CA, USA; View further author information
,
Alexander EgebergDepartment of Dermatology and Allergy, Herlev and Gentofte Hospital, Hellerup, Denmark; ORCID Iconhttp://orcid.org/0000-0001-8257-1816View further author information
ORCID Icon,
Jacob P. ThyssenDepartment of Dermatology and Allergy, Herlev and Gentofte Hospital, Hellerup, Denmark; View further author information
&
Jashin J. WuDepartment of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USACorrespondence[email protected]
View further author information
Pages 100-101 | Received 14 Feb 2017, Accepted 08 May 2017, Published online: 30 Jun 2017

References

  • Krueger GG, Papp KA, Stough DB, et al. A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol. 2002;47:821–33.
  • Gordon KB, Papp KA, Hamilton TK, et al. Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial. JAMA. 2003;290:3073–80. Erratum in: JAMA. 2004;291:1070.
  • Leonardi CL, Powers JL, Matheson RT, et al. Etanercept as monotherapy in patients with psoriasis. N Engl J Med. 2003;349:2014–22.
  • Simpson EL, Bieber T, Guttman-Yassky E, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016;375:2335–48.
  • Kimball AB, Gladman D, Gelfand JM, et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol. 2008;58:1031–42.
  • Khalid U, Hansen PR, Gislason GH, et al. Psoriasis and new-onset diabetes: a Danish nationwide cohort study. Diabetes Care. 2013;36:2402–7.
  • Phan C, Sigal ML, Lhafa M, et al. Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases. Ann Dermatol Venereol. 2016;143:264–74.
  • Miller IM, Ellervik C, Zarchi K, et al. The association of metabolic syndrome and psoriasis: a population- and hospital-based cross-sectional study. J Eur Acad Dermatol Venereol. 2015;29:490–7.
  • Prodanovich S, Kirsner RS, Kravetz JD, et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol. 2009;145:700–3.
  • Andersen YM, Egeberg A, Gislason GH, et al. Autoimmune diseases in adults with atopic dermatitis. J Am Acad Dermatol. 2017;76:274–80.e1.
  • Paternoster L, Standl M, Waage J, et al. Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat Genet. 2015;47:1449–56.
  • Andersen YM, Egeberg A, Gislason GH, et al. Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis. J Allergy Clin Immunol. 2016;138:310–12.e3.
  • Silverberg JI. Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies. Allergy. 2015;70:1300–8.
  • Su VY, Chen TJ, Yeh CM, et al. Atopic dermatitis and risk of ischemic stroke: a nationwide population-based study. Ann Med. 2014;46:84–9.
  • Zhang A, Silverberg JI. Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis. J Am Acad Dermatol. 2015;72:606–16.e4.
  • Standl M, Tesch F, Baurecht H, et al. Association of atopic dermatitis with cardiovascular risk factors and diseases. J Invest Dermatol. 2017;137:1074–81.
  • Andersen YM, Egeberg A, Gislason GH, et al. Adult atopic dermatitis and the risk of type 2 diabetes. J Allergy Clin Immunol. 2017;139:1057–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.